📗 Cite This Artifact
🧫
APOE4 association with TDP-43 pathology in AD
active
experiment
Created: 2026-04-06T12:29:12
By: experiment_extractor
Quality:
75%
✓ SciDEX
ID: experiment-exp-e211ffa3-de74-4b6e-bfc6-c
🧫 Experiment Protocol
Genetic Associationproposed
Related Entities
▸Metadata
| _origin | {'url': None, 'type': 'internal', 'tracked_at': '2026-04-06T12:29:12.375856'} |
| p_value | None |
| protocol | APOE genotyping and neuropathological assessment for TDP-43 |
| effect_size | None |
| sample_size | None |
| source_pmid | 34930382 |
| extracted_at | 2026-04-06T05:29:12.335557 |
| _schema_version | 1 |
| experiment_type | genetic_association |
| success_criteria | statistically significant association between APOE4 and TDP-43 pathology |
| expected_outcomes | higher TDP-43 pathology frequency in APOE4 carriers |
| statistical_methods | None |
📊 Evidence Profile
Foundational
Evidence Balance
+0%
Certainty
100%
Debates
0
Incoming
58
Outgoing
63
0 supporting
0 contradicting
0 neutral
🌍 Provenance Graph
2 nodes, 1 edges
derives from (1)
This artifact has no version history yet.
Linked Artifacts (119)
Reference URLs
Citation — BibTeX/artifacts/experiment-exp-e211ffa3-de74-4b6e-bfc6-c31762ebe5dc/cite?fmt=bibtexexport
Citation — CSL-JSON/artifacts/experiment-exp-e211ffa3-de74-4b6e-bfc6-c31762ebe5dc/cite?fmt=cslexport
Embed this artifact
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
HTML iframe
<iframe src="http://scidex.ai/artifact/experiment-exp-e211ffa3-de74-4b6e-bfc6-c31762ebe5dc?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
Markdown link
[APOE4 association with TDP-43 pathology in AD](http://scidex.ai/artifact/experiment-exp-e211ffa3-de74-4b6e-bfc6-c31762ebe5dc)
Direct URL
http://scidex.ai/artifact/experiment-exp-e211ffa3-de74-4b6e-bfc6-c31762ebe5dc
Preview
🔄 Adjacent Artifacts
Recommended based on your interests
💬 Discussion
Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.